piperaquine has been researched along with puromycin in 1 studies
Studies (piperaquine) | Trials (piperaquine) | Recent Studies (post-2010) (piperaquine) | Studies (puromycin) | Trials (puromycin) | Recent Studies (post-2010) (puromycin) |
---|---|---|---|---|---|
638 | 227 | 497 | 5,828 | 1 | 311 |
Protein | Taxonomy | piperaquine (IC50) | puromycin (IC50) |
---|---|---|---|
30S ribosomal protein S6 | Escherichia coli K-12 | 0.9 | |
30S ribosomal protein S7 | Escherichia coli K-12 | 0.9 | |
50S ribosomal protein L15 | Escherichia coli K-12 | 0.9 | |
50S ribosomal protein L10 | Escherichia coli K-12 | 0.9 | |
50S ribosomal protein L11 | Escherichia coli K-12 | 0.9 | |
50S ribosomal protein L7/L12 | Escherichia coli K-12 | 0.9 | |
50S ribosomal protein L19 | Escherichia coli K-12 | 0.9 | |
50S ribosomal protein L1 | Escherichia coli K-12 | 0.9 | |
50S ribosomal protein L20 | Escherichia coli K-12 | 0.9 | |
50S ribosomal protein L27 | Escherichia coli K-12 | 0.9 | |
50S ribosomal protein L28 | Escherichia coli K-12 | 0.9 | |
50S ribosomal protein L29 | Escherichia coli K-12 | 0.9 | |
50S ribosomal protein L31 | Escherichia coli K-12 | 0.9 | |
50S ribosomal protein L31 type B | Escherichia coli K-12 | 0.9 | |
50S ribosomal protein L32 | Escherichia coli K-12 | 0.9 | |
50S ribosomal protein L33 | Escherichia coli K-12 | 0.9 | |
50S ribosomal protein L34 | Escherichia coli K-12 | 0.9 | |
50S ribosomal protein L35 | Escherichia coli K-12 | 0.9 | |
50S ribosomal protein L36 | Escherichia coli K-12 | 0.9 | |
30S ribosomal protein S10 | Escherichia coli K-12 | 0.9 | |
30S ribosomal protein S11 | Escherichia coli K-12 | 0.9 | |
30S ribosomal protein S12 | Escherichia coli K-12 | 0.9 | |
30S ribosomal protein S13 | Escherichia coli K-12 | 0.9 | |
30S ribosomal protein S16 | Escherichia coli K-12 | 0.9 | |
30S ribosomal protein S18 | Escherichia coli K-12 | 0.9 | |
30S ribosomal protein S19 | Escherichia coli K-12 | 0.9 | |
30S ribosomal protein S20 | Escherichia coli K-12 | 0.9 | |
30S ribosomal protein S2 | Escherichia coli K-12 | 0.9 | |
30S ribosomal protein S3 | Escherichia coli K-12 | 0.9 | |
30S ribosomal protein S4 | Escherichia coli K-12 | 0.9 | |
30S ribosomal protein S5 | Escherichia coli K-12 | 0.9 | |
30S ribosomal protein S8 | Escherichia coli K-12 | 0.9 | |
30S ribosomal protein S9 | Escherichia coli K-12 | 0.9 | |
50S ribosomal protein L13 | Escherichia coli K-12 | 0.9 | |
50S ribosomal protein L14 | Escherichia coli K-12 | 0.9 | |
50S ribosomal protein L16 | Escherichia coli K-12 | 0.9 | |
50S ribosomal protein L23 | Escherichia coli K-12 | 0.9 | |
30S ribosomal protein S15 | Escherichia coli K-12 | 0.9 | |
50S ribosomal protein L17 | Escherichia coli K-12 | 0.9 | |
50S ribosomal protein L21 | Escherichia coli K-12 | 0.9 | |
50S ribosomal protein L30 | Escherichia coli K-12 | 0.9 | |
50S ribosomal protein L6 | Escherichia coli K-12 | 0.9 | |
30S ribosomal protein S14 | Escherichia coli K-12 | 0.9 | |
30S ribosomal protein S17 | Escherichia coli K-12 | 0.9 | |
30S ribosomal protein S1 | Escherichia coli K-12 | 0.9 | |
50S ribosomal protein L18 | Escherichia coli K-12 | 0.9 | |
Puromycin-sensitive aminopeptidase | Homo sapiens (human) | 6.075 | |
50S ribosomal protein L2 | Escherichia coli K-12 | 0.9 | |
50S ribosomal protein L3 | Escherichia coli K-12 | 0.9 | |
50S ribosomal protein L24 | Escherichia coli K-12 | 0.9 | |
50S ribosomal protein L4 | Escherichia coli K-12 | 0.9 | |
50S ribosomal protein L22 | Escherichia coli K-12 | 0.9 | |
50S ribosomal protein L5 | Escherichia coli K-12 | 0.9 | |
30S ribosomal protein S21 | Escherichia coli K-12 | 0.9 | |
50S ribosomal protein L25 | Escherichia coli K-12 | 0.9 | |
50S ribosomal protein L36 2 | Escherichia coli K-12 | 0.9 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Avery, VM; Baell, JB; Ban, K; Beveridge, JG; Blundell, S; Charman, SA; Chavchich, M; Chiu, FCK; Creek, D; Cuellar, ME; Dahlin, JL; Diab, S; Dingjan, T; Duffy, S; Edstein, MD; Ellis, K; Fletcher, S; Harjani, JR; Huang, F; Lucantoni, L; Marfurt, J; Noviyanti, R; Price, RN; Ralph, SA; Shi, DH; Strasser, JM; Teguh, S; Walters, MA; Wirjanata, G; Xue, L | 1 |
1 other study(ies) available for piperaquine and puromycin
Article | Year |
---|---|
3,3'-Disubstituted 5,5'-Bi(1,2,4-triazine) Derivatives with Potent in Vitro and in Vivo Antimalarial Activity.
Topics: Animals; Antimalarials; Chloroquine; Drug Resistance; Humans; In Vitro Techniques; Magnetic Resonance Spectroscopy; Mice; Molecular Structure; Plasmodium; Species Specificity; Structure-Activity Relationship; Triazines | 2019 |